Adi Livneh
Directeur/Bestuurslid bij New N.I. Medical (2011) Ltd.
Profiel
Adi Livneh is currently a Director at New N.I.
Medical (2011) Ltd.
In the past, Livneh worked as the Chief Executive Officer at Tefron Ltd.
from 2008 to 2009.
Actieve functies van Adi Livneh
| Bedrijven | Functie | Begin |
|---|---|---|
New N.I. Medical (2011) Ltd.
 New N.I. Medical (2011) Ltd. Medical SpecialtiesHealth Technology New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Adi Livneh
| Bedrijven | Functie | Einde |
|---|---|---|
| TEFRON LTD. | President | 17-11-2009 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TEFRON LTD. | Consumer Non-Durables |
| Bedrijven in privébezit | 1 |
|---|---|
New N.I. Medical (2011) Ltd.
New N.I. Medical (2011) Ltd. Medical SpecialtiesHealth Technology New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev. | Health Technology |
